Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

Clinical trial NCT03258099 · UNKNOWN

Trial details

NCT number: NCT03258099
Sponsor: Cui Yimin
Status: UNKNOWN
Study type: OBSERVATIONAL

Solid Tumor Capecitabine Drug-Related Side Effects and Adverse Reactions Pharmacogenetics Pharmacokinetics

Start date: 2017-12-28
Primary completion: 2019-10-01
Enrollment: 2200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.